The stock of U.S. pharmaceutical giant Eli Lilly (LLY) is up 3% on news that rival Pfizer (PFE) has ended development of its experimental ...

Dietitians’ No. 1 weight-loss pick at Dunkin’ is the Egg & Cheese English Muffin Sandwich. It’s low in calories and added ...

A new study led by researchers at the Arkansas Agricultural Experiment Station has found that the popular class of weight-loss drugs known as GLP-1 agonists—including Mounjaro, Ozempic, and Wegovy—is ...

The increasing use of GLP-1 medications for weight loss is leading to significant changes in food preferences, with users ...

Manhattanites are flocking to restaurants that are being compared to Applebee's and TGI Friday's in search of simple meals - ...

After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...

Smoothie King had already seen the writing on the wall, too, and created a menu section ... use in helping lose weight, GLP-1s saw a 300 percent increase in use between 2020 and 2022. GLP-1s were ...

Donald Trump’s team gutted the Biden administration’s plan as part of a sprawling 438-page regulation update that tweaks how beneficiaries get drug coverage ...

Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs known as GLP-1 agonists used to treat people with type 2 diabetes. While some GLP-1 agonists are used for weight loss in people ...

The “Misery” star went on a weight-loss journey several years ago after being diagnosed with Type 2 diabetes. The Oscar winner admitted to the magazine that she “used to eat terribly ...

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year ...